European Society of Intensive Care Medicine study of therapeutic hypothermia (32 - 35°C) for intracranial pressure (ICP) reduction after traumatic brain injury

niversity of Edinburgh and NHS Lothian (UK)0 个研究点目标入组 600 人开始时间: 2008年5月30日最近更新: 2018年9月24日

试验速览

阶段: 未知
状态: 已完成
发起方
入组人数: 600

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

2011 protocol in http://www.ncbi.nlm.nih.gov/pubmed/21226939 2013 results in http://www.ncbi.nlm.nih.gov/pubmed/24004918 2015 results in http://www.ncbi.nlm.nih.gov/pubmed/26444221 2018 results in http://www.ncbi.nlm.nih.gov/pubmed/30168413

研究设计

研究类型: Interventional

入排标准

性别: All

入选标准

•Current inclusion criteria as of 14/08/2012:
•1. Believed to be legal age for consent to take part in research, either sex
•2. Primary closed traumatic brain injury
•3. Raised ICP greater than 20 mmHg for greater than or equal to 5 minutes after first line treatments with no obvious reversible cause e.g. patient position, coughing, inadequate sedation
•4. Less than or equal to 10 days from the initial head injury
•5. Cooling device or technique available for greater than 48 hours
•6. Core temperature greater than or equal to 36°C (at the time of randomisation)
•7. An abnormal computed tomography (CT) scan of the brain. This is defined as one that shows haematoma, contusion, swelling, herniation or compressed basal cisterns.
•Previous inclusion criteria as of 01/07/2009 and until 14/08/2012:
•1. Believed to be legal age for consent to take part in research to 65 years of age, either sex
•4. Less than or equal to 72 hours from the initial head injury
•Initial information at time of registration (2008):
•1. Adults aged 16 - 65 years, both males and females
•2. Primary, closed traumatic brain injury
•3. An abnormal computed tomography (CT) scan of brain, Marshall grade greater than 1
•4. Refractory increased intracranial pressure (ICP) greater than 20 mmHg for at least 30 minutes (refractory to first line interventions including mechanical ventilation, sedation, analgesia ± muscle relaxant, head of bed elevation, with monitoring of CVP and invasive arterial pressure)
•5. Core temperature greater than 36°C (at the time of randomisation)
•6. Cooling device or technique available for greater than 48 hours

排除标准

•Current information as of 01/07/2009:
•1. Patient already receiving therapeutic hypothermia treatment
•2. Administration of barbiturate infusion prior to randomisation
•3. Unlikely to survive for the next 24 hours in the opinion of the ICU Consultant or Consultant Neurosurgeon treating the patient
•4. Temperature less than or equal to 34°C at hospital admission
•5. Pregnancy
•Initial information at time of registration:
•1. Patients with bilateral fixed and dilated pupils
•2. Unable to monitor ICP or patients with ICP less than 20 mmHg
•3. Patients who have received barbiturates prior to randomisation
•4. Where there is documented brainstem involvement
•5. Moribund condition on admission

研究者

发起方

niversity of Edinburgh and NHS Lothian (UK)

相似试验

已完成

2 期

Cisplatin, capecitabine, and radiation therapy with or without cetuximab in treating patients with oesophageal cancerOesophageal cancerCancer

ISRCTN47718479Velindre NHS Trust (UK)420

已完成

不适用

Efficacy of an educational school-based intervention to reduce prevalence of obesity in childhood in CataloniaObesity

ISRCTN29247645niversity of Rovira i Virgili (Universitat Rovira i Virgili) (Spain)1,400

已完成

4 期

Standardised, Concentrated and Additional Macronutrients in neonatal Parenteral nutrition study

ISRCTN76597892iverpool Women's Hospital NHS Foundation Trust (UK)150

已完成

不适用

A multicentre, prospective, randomised study of the value of a single dose of intravesical Mitomycin-C in preventing the development of bladder tumours following nephroureterectomy for transitional cell carcinoma (TCC) of the upper urinary tractpper tract TCC bladderMalignant neoplasm of bladderCancer

ISRCTN36343644Sussex NHS Research Consortium (UK)268

进行中（未招募）

3 期

Renal Adjuvant Multiple Arm Randomised Trial (RAMPART)Resected primary renal cell carcinomaMalignant neoplasm of kidney, except renal pelvisCancer

ISRCTN53348826niversity College London1,750